InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Tuckson Reed Vaughn, 董事. Director active across 2 companies, notably Henry Schein INC. Aggregated, 9 reports have been published. Activity tracked since 11 June 2021. The latest transaction was disclosed on 6 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tuckson Reed Vaughn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
2,577 股0Common Stock, par value $0.01 per shareSEC:0001511051-26-000003:0
487 股@ US$71.1422.0% 占其流量Common Stock, par value $0.01 per shareSEC:0000950170-25-085587:0
572 股@ US$70.3136.0% 占其流量Common Stock, par value $0.01 per shareSEC:0000950170-25-034822:0
495 股@ US$76.8833.1% 占其流量Common Stock, par value $0.01 per shareSEC:0000950170-24-026300:0
48,639 股@ US$9.10100.0% 占其流量Common StockSEC:0000899243-23-016482:0
446 股@ US$78.1530.9% 占其流量Common Stock, par value $0.01 per shareSEC:0001209191-23-019640:0
2,250 股0Common Stock, par value $0.01 per shareSEC:0001209191-23-015725:0
2,028 股0Common Stock, par value $0.01 per shareSEC:0001209191-22-020159:0
2,217 股0Common Stock, par value $0.01 per shareSEC:0001209191-21-040609:0
9 条申报中的 9 条
About Tuckson Reed Vaughn
Tuckson Reed Vaughn is Administrateur at Henry Schein INC and CTI Biopharma CORP. He has 9 filings in total, and the sampled recent filings cover the period from 2021-06-15 to 2026-03-09, with the transaction nature shown as Attribution.
